$25.82
+0.30 (+1.18%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+5.39%
1Y
+166.46%
YTD
+24.02%
Open$25.44
Previous Close$25.52
Day High$26.42
Day Low$25.32
52W High$27.65
52W Low$8.67
Volume—
Avg Volume990.2K
Market Cap2.83B
P/E Ratio—
EPS$-2.36
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$22.49
Above
SMA 200
$14.32
Above
RSI (14)
37.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
20 analysts
Price Target
+409.3% upside
Current
$25.82
$25.82
Target
$131.49
$131.49
$82.08
$131.49 avg
$141.61
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 8.73M | 603.96M | 550.96M |
| Net Income | -266,943,027 | -173,219,826 | -162,867,502 |
| Profit Margin | -3,060.0% | -28.7% | -29.6% |
| EBITDA | -278,569,294 | -273,358,868 | -247,027,649 |
| Free Cash Flow | — | -130,399,233 | -192,377,550 |
| Rev Growth | — | +13.0% | +19.7% |
| Debt/Equity | — | 0.20 | 0.19 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |